King Wealth Impel Pharmaceuticals Inc Transaction History

King Wealth

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$8.33 - $12.14 $166,600 - $242,800	-20,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$8.38 - $26.13 $167,600 - $522,600	20,000 New	20,000 $244,000

14.4K

Ticker IMPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,738,800
Market Cap $475K
Description
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

Stay updated on King Wealth with notifications on news.